INTRODUCTION
============

Operative laparoscopic surgery has expanded its boundaries exponentially over the past 2 decades. In this regard, laparoscopic surgeons continue to face one persistent problem. This problem is the ability to safely and effectively remove a variety of laparoscopically resected tissues from the abdominal cavity. Of course, one solution to this problem is to enlarge one of the laparoscopic trocar incisions to remove the tissue specimen intact. This solution is, however, counterproductive to the concept of minimally invasive surgery. Another solution is to morcellate the specimen with some type of morcellation device. Morcellation, however, is not acceptable in many surgical cases, because of the risk of dissemination of infection and/or malignant neoplasia. Also, morcellation may compromise adequate pathologic examination of the resected tissue specimen.

Several laparoscopic tissue retrieval sacs exist to facilitate removal of intact surgical tissue specimens (eg, E-Sac, ENDO CATCH™, Pleatman Sac®, Endobag®). Though these sacs are very effective in isolating a surgical specimen from the peritoneal cavity and the abdominal incision, they all have one inherent disadvantage. This disadvantage is that they distend as the tissue inside of them is brought up to the interior aspect of the abdominal wall in preparation for removal from the abdominal cavity. The specimen becomes trapped in the abdominal cavity if the diameter of the distended sac becomes larger than the diameter of the incision. A variety of maneuvers can be attempted using traditional surgical instrumentation to facilitate the removal of these laparoscopically resected tissue specimens with variable success. In many cases, a laparoscopic surgeon is frustrated by either rupturing the laparoscopic retrieval sac or enlarging an otherwise small incision. Ghezzi et al^[@B1]^ recently published the only study that showed that large gynecologic masses could be safely and successfully removed by morcellation of the masses in the laparoscopic tissue retrieval sac through a standard 10-mm trocar incision.

With the above considerations in mind, a device is needed to counteract the physical constraints of small incisions and the physical characteristics of a laparoscopic tissue retrieval sac. First, such a device should minimize the diameter of the laparoscopic tissue retrieval sac and the enclosed surgical specimen. Second, the device should help protect the integrity of the sac/surgical specimen. Third, it should facilitate removal of the sac/surgical specimen by allowing axial traction to be applied to the device and not the sac/surgical specimen. Such a device has been developed by Schellpfeffer.^[@B2]--[@B4]^ It is patterned after an obstetrical forceps^[@B5]^ and fulfills all of the above requirements. Recently, Brown et al^[@B6]^ confirmed this concept, demonstrating that standard obstetrical forceps can be used to extract nephrectomy specimens enclosed in a laparoscopic retrieval sac. As illustrated in **[Figure 1](#F1){ref-type="fig"}a**, the device consists of a left and right side. Each side has a handle, a shank, a portion of the locking mechanism, and a blade. Each blade\'s width is 2cm. The device freely articulates and disarticulates to allow for placement around a sac/specimen **([Figure 1](#F1){ref-type="fig"}b)**. The size and curve of the blades allow for easy introduction of each portion of the device around the laparoscopic tissue retrieval sac/specimen through a standard incision made for a 10/12-mm trocar. Once applied to the sac/specimen, the device minimizes the diameter of the sac/specimen and protects its integrity. Axial traction is then applied to the device to facilitate removal of the sac/specimen.

![The laparoscopic tissue retrieval forceps is seen (a) assembled and (b) disassembled.](jls0041128010001){#F1}

The purpose of this study was to demonstrate the usefulness of this newly developed laparoscopic tissue retrieval device in removing trapped surgical tissue specimens resected at the time of operative gynecologic surgery.

MATERIALS AND METHODS
=====================

This study was a consecutive series of patients over a 5-year period all operated on by the author. The inclusion criteria for this study were as follows: 1) a laparoscopically resected tissue specimen placed within a laparoscopic tissue retrieval sac not able to be removed from the abdominal cavity by axial traction on the sac.2) all of the extractions were performed through a subumbilical trocar incision that had previously accommodated a standard 10/12-mm disposable laparoscopic trocar without enlarging the incision.3) no cases of obvious malignant or grossly infected surgical tissue specimens were included in this study.

Forty-two operative gynecologic laparoscopic procedures were performed that met the criteria of this study. All surgical procedures were performed by the author, and the study was approved by the hospital Institutional Review Board.

Extraction Procedure
--------------------

The extraction procedure begins after an unsuccessful attempt at removal of the laparoscopic tissue extraction sac and the enclosed tissue specimen through the subumbilical incision site after removal of the trocar. The sac/specimen is directly visualized using a 5-mm laparoscope placed through a previously placed lower abdominal 5-mm accessory port. Direct laparoscopic visualization of the sac/specimen and the forceps placement is performed continuously throughout the extraction process. **[Figures 2](#F2){ref-type="fig"} through [](#F3){ref-type="fig"}[4](#F4){ref-type="fig"}** demonstrate the application of the device to a laparoscopic tissue retrieval sac/specimen, and removal of the sac/specimen from the abdominal cavity. **[Figure 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}** show an exterior view of the placement of the right and left blade, respectively. **[Figure 4](#F4){ref-type="fig"}** illustrates the 2 blades locked in place around the sac/specimen with traction being applied for removal from the abdominal cavity. After removal of the sac/specimen, the trocar incision site is inspected to identify any possible extension of the trocar incision fascial defect that may have occurred as a result of placement of the device or removal of the sac/specimen. The fascial defect from the subumbilical trocar is then closed with interrupted synthetic delayed absorption sutures. Postoperatively, all of the patients are seen for a routine postoperative examination between 2 weeks to 6 weeks after the surgery. All patients are queried and examined for any adverse outcomes. Long-term outcomes are obtained if possible.

![The right forceps blade (lower blade) is placed along side of the tissue retrieval sac. The retrieval sac is always oriented anterior or in front of the blade placement.](jls0041128010002){#F2}

![The left forceps blade (upper blade) is placed alongside of the tissue retrieval sac. The left forceps blade is placed in between the right blade and the retrieval sac.](jls0041128010003){#F3}

![The forceps blades are aligned and locked together. Extraction of the tissue retrieval sac is accomplished by applying axial traction to the locked forceps.](jls0041128010004){#F4}

RESULTS
=======

Of the 42 patients included in this study, 34 had successful removal of the laparoscopic tissue retrieval sac and surgical specimen. **[Table 1](#T1){ref-type="table"}** lists the procedures performed and the outcomes. In 8 patients (19%), the sac/specimen was unable to be removed successfully. All of the unsuccessful cases were related to the size of the tissue to be removed. In these cases, the subumbilical incision was enlarged, and the specimen was removed successfully. There were no sac ruptures. All of the specimens were removed intact for standard pathologic examination. Tissue volumes were provided from the pathology reports. Several specimens were drained inside the laparoscopic retrieval sac, and one specimen was divided due to its size prior to placement in a sac. There were no other intraoperative adverse outcomes among the study population. Postoperatively, 3 patients (7%) had superficial subumbilical trocar-site wound infections. Each of the infections responded quickly and completely to oral antibiotic therapy. One patient had postoperative urinary retention requiring continuous bladder catheterization for 24 hours. Two patients, done on an emergent basis, failed to follow up for postoperative visits and were lost to follow-up. In the short-term follow-up over a 2-week to 6-week period, there were no incisional hernias in the study population patients who returned for follow-up examinations. There were no other postoperative complications as a result of the use of the device in this study population. Fifteen of 42 patients (35.7%) were seen in long-term follow-up from 6 months to 5 years. There were no long-term adverse outcomes as a result of the use of the device.

###### 

Procedures and Outcomes

  Patient   Age   Weight   Clinical Indication[^a^](#TF1-1){ref-type="table-fn"}   Procedure[^a^](#TF1-1){ref-type="table-fn"}   Pathology                Tissue Volume (cc)                            Outcome      Complications
  --------- ----- -------- ------------------------------------------------------- --------------------------------------------- ------------------------ --------------------------------------------- ------------ ----------------------------------------
  1         45    159      Pelvic Pain/Mass                                        LSO                                           Hydrosalpinx             25                                            Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  2         40    147      Complex Pelvic Mass                                     LSO                                           Hydrosalpinx             15[^b^](#TF1-2){ref-type="table-fn"}          Successful   LTF
  3         47    148      Pelvic Pain S/P Hyst                                    BSO                                           Hem. C-L Cysts           L-35/R-31.5                                   Successful   None
  4         54    166      Complex Pelvic Mass                                     BSO                                           Serous Cystadenoma       L-42/R-18                                     Failed       None[^d^](#TF1-4){ref-type="table-fn"}
  5         34    117      Pelvic Pain                                             LSO                                           Endometrioma             36.7                                          Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  6         81    173      Postmenopausal Mass                                     LSO                                           Serous Cystadenoma       30                                            Successful   None
  7         44    187      Complex Pelvic Mass                                     LSO                                           Serous Cystadenoma       168                                           Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  8         72    144      Postmenopausal Mass                                     LSO                                           Serous Cystadenoma       9.5                                           Successful   None
  9         34    165      Complex Pelvic Mass                                     L Cyst                                        Benign Cystic Teratoma   8.2                                           Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  10        45    150      Pelvic Pain/Mass                                        LSO                                           Serous Cystadenoma       34.9                                          Failed       None
  11        74    107      Postmenopausal Mass                                     BSO                                           Ovarian Fibroma          R-2.8/L-22.8                                  Successful   None
  12        30    161      Pelvic Pain/Mass                                        RSO                                           Hem. C-L Cyst            8.4                                           Successful   None
  13        33    202      Acute Pelvic Pain                                       LSO                                           Adnexal Torsion          523                                           Failed       None
  14        44    202      Pelvic Pain/Mass                                        BSO                                           Endometrioma             R-13.4/L-10.9                                 Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  15        46    199      Pelvic Pain S/P Hyst                                    BSO                                           Normal T/O               56                                            Successful   None
  16        54    155      Postmenopausal Mass                                     BSO                                           Benign Cystic Teratoma   6.7[^b^](#TF1-2){ref-type="table-fn"}         Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  17        67    175      Postmenopausal Mass                                     BSO                                           Serous Cystadenoma       R-3.1/L-5.2                                   Successful   SWI[^d^](#TF1-4){ref-type="table-fn"}
  18        49    188      Pelvic Pain/Mass                                        RSO                                           C-L Cyst                 48                                            Successful   SWI
  19        34    194      Pelvic Pain/Mass                                        LSO                                           TOA                      96                                            Failed       None
  20        34    184      Acute Pelvic Pain                                       LSO                                           Torsed Cystadenoma       256[^c^](#TF1-3){ref-type="table-fn"}         Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  21        38    158      Pelvic Pain/Mass                                        RSO                                           Serous Cystadenoma       8                                             Successful   None
  22        42    112      Pelvic Pain/Mass                                        BSO                                           Paratubal Cyst           L-28/R-35                                     Successful   None
  23        34    337      Complex Pelvic Mass                                     L Cyst                                        Benign Cystic Teratoma   22.4[^b^](#TF1-2){ref-type="table-fn"}        Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  24        60    197      Postmenopausal Mass                                     LSO                                           Hydrosalpinx             33.5                                          Successful   None
  25        45    207      Metastatic Breast CA                                    BSO                                           Normal T/O               38.4                                          Successful   None
  26        25    150      Chronic PID                                             BS                                            Hydrosalpinx             14.5                                          Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  27        55    227      Postmenopausal Mass                                     BSO                                           Serous Cystadenoma       L-113/R-6[^b^](#TF1-2){ref-type="table-fn"}   Successful   None
  28        46    158      Leiomyoma Uteri                                         BSO w/VH                                      Normal T/O               22.4                                          Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  29        39    200      Pelvic Pain/Mass                                        RSO                                           Hem. C-L Cyst            17.5                                          Successful   None
  30        40    140      Pelvic Pain/Mass                                        RSO                                           Hydrosalpinx             12                                            Successful   None
  31        53    176      Pelvic Pain/Mass                                        BSO                                           Serous Cystadenoma       R-19.9/L-16.6                                 Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  32        40    N/A      Acute Pelvic Pain                                       LSO                                           Torsed Hydrosalpinx      121                                           Failed       LTF
  33        48    194      Familial Ovarian CA                                     BSO                                           Normal T/O               22.3                                          Successful   None[^d^](#TF1-4){ref-type="table-fn"}
  34        17    166      Pelvic Pain/Mass                                        L Cyst                                        Benign Cystic Teratoma   9.4                                           Successful   None
  35        50    148      Pelvic Pain/Mass                                        BSO                                           Hem. C-L Cyst            33.5                                          Successful   PUR[^d^](#TF1-4){ref-type="table-fn"}
  36        38    173      Pelvic Pain/Mass                                        RO                                            C-L Cyst                 10                                            Successful   None
  37        54    130      Post menopausal Mass                                    LSO                                           Serous Cystadenoma       68.2[^b^](#TF1-2){ref-type="table-fn"}        Successful   None
  38        69    227      Postmenopausal Mass                                     BSO                                           Lipoleiomyoma            R-3.5L-64.7                                   Failed       None
  39        54    240      Postmenopausal Mass                                     RO                                            Benign Cystic Teratoma   351[^b^](#TF1-2){ref-type="table-fn"}         Failed       None
  40        45    149      L Pelvic Mass                                           LO                                            Benign Cystic Teratoma   22.4[^b^](#TF1-2){ref-type="table-fn"}        Success      None
  41        42    154      Bil Pelvic Masses                                       Bil Cyst                                      Benign Cystic Teratoma   R-28.1/L-7                                    Failed       None
  42        43    147      L Pelvic Mass                                           L Cyst                                        L Peritubal Cyst         8.2                                           Success      None

LSO=left salpingo-oophorectomy, RSO=right salpingo-oophorectomy, BSO=bilateral salpingo-oophorectomy, L=Cyst left cystectomy, C-L corpus luteum, LTF=lost to follow-up, SWI=superficial wound infection, VH=vaginal hysterectomy, T/O=tube and ovary, TOA=tubo-ovarian abscess, N/A not available, PUR=postop urinary retention, Hem=hemorrhagic, Hyst=hysterectomy, CA=cancer.

Mass aspirated.

Mass morcellated.

Long-term follow-up---6 months to 5 years.

DISCUSSION
==========

This study showed that this novel medical device is potentially both efficacious and safe to use in facilitating the removal of trapped laparoscopically resected tissue specimens. By design, this study demonstrated the efficacy of the forceps in that the major criteria for entry into the study was the inability to remove the tissue retrieval sac/specimen from the abdominal cavity with ordinary axial traction on the retrieval sac. Over 80% of the trapped extraction sacs/specimens were successfully removed using the forceps. The majority of the forceps failures were due to the size of the tissue specimen. The safety of the device was also demonstrated in that there were no major complications observed as a result of using the forceps. The postoperative infections were all minor and well within the range of current reports of infectious complications for operative gynecologic laparoscopy.^[@B7]--[@B9]^ Long-term follow-up in greater than a third of the patients also demonstrated no adverse outcomes from use of the device.

There are, however, several points that need to be emphasized in using this device. First, it is imperative that the device placement, locking, and extraction process continually be observed through the laparoscope as it is performed to avoid any possible injury to the intraabdominal organs. Injury to intraabdominal organs is also prevented by maintaining an adequate pneumoperitoneum. This is facilitated by holding the tissue extraction sac in close apposition to the inferior aspect of the anterior abdominal wall during the forceps placement. Secondly, to allow for quick and easy placement and locking of the device, proper initial orientation of the instrument is essential. The extraction sac must always be kept anterior or in front of the blade placement. The device itself should always be assembled outside the abdomen with the locking pin of the right blade facing up and the left blade label "L" facing up. Each blade is then introduced separately. The right or bottom blade is placed first beneath or posterior to the anteriorly oriented extraction sac. Then the left or top blade is placed between the right blade handle and the anteriorly oriented extraction sac. This procedure will ensure that the blades will always be oriented correctly around the specimen for easy and effective locking and extraction. Finally, the trocar site used for the extraction must be inspected to ensure that the fascial defect is properly closed. On occasion, the fascial defect is enlarged during the extraction process. As long as the entire extent of the fascial defect is identified, it is easily closed in the routine fashion as is done with any other trocar site \>10mm as recommended by Kadar et al.^[@B10]^

It appears that use of this device conveys no significant additional risk, and it does allow the laparoscopic surgeon another means to facilitate removal of laparoscopically resected tissue specimens. Prudent use of this device is, however, imperative. Following the general guidelines recommended for performance of safe operative laparoscopic surgery is still paramount. As general use of this device increases, continued monitoring and re-assessment of its capabilities and potential ultimate limitations is also important. Certainly a larger cohort of patients needs to be studied to confirm the efficacy and safety of this device. Future clinical uses for this device could include its use in a wider range of laparoscopic surgeries. Prototypes are already under development for larger versions of the device to allow bigger laparoscopic tissue retrieval sacs and specimens to be removed through mini-laparotomy type incisions. Smaller prototypes are also in development for use in pediatric operative laparoscopic cases.

CONCLUSIONS
===========

This laparoscopic tissue retrieval device is a novel medical device that allows an easy and effective means to remove trapped laparoscopic tissue retrieval sacs with enclosed tissue specimens.

[^1]: The author is the President and Chief Executive Officer of Laparoscopic Technologies, Inc. the distributor of this medical device, and he is the owner of the patent for this medical device. He has no financial relationship with Harbor Machining, Inc. the manufacturer of the forceps.

[^2]: Harbor Machining, Inc. Kenosha, Wisconsin, is recognized as the manufacturer of this medical device as well as the prototypes used in the development of the device.
